The private sector hasn’t so far been able to deliver nearly enough tests to meet the huge demand in the U.S., more than six weeks after the FDA allowed private companies to manufacture test kits https://t.co/H5sAD18kx3

— The Wall Street Journal (@WSJ) April 20, 2020